Randomized Trial of the Immunogenicity and Safety of the Hepatitis B Vaccine Given in an Accelerated Schedule Coadministered with the Human Papillomavirus Type 16/18 AS04-Adjuvanted Cervical Cancer Vaccine

The human papillomavirus type 16/18 (HPV-16/18) AS04-adjuvanted cervical cancer vaccine is licensed for females aged 10 years and above and is therefore likely to be coadministered with other licensed vaccines, such as hepatitis B. In this randomized, open-label study, we compared the immunogenicity...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Leroux-Roels, Geert, Haelterman, Edwige, Maes, Cathy, Levy, Jack, De Boever, Fien, Licini, Laurent, David, Marie-Pierre, Dobbelaere, Kurt, Descamps, Dominique
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2011
נושאים:
Vaccine Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3165228/
https://ncbi.nlm.nih.gov/pubmed/21734063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00539-10
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים